• SENSEX 76,583.04
    12.69 (+0.02%)
  • BANKNIFTY 57,172.00
    -237.60 (--0.41%)
  • Power Fin.Corpn.
    345.65 330.05(%)
  • Netweb Technol.
    5,374.90 5,810.00(%)
  • NTPC
    332.55 414.40(%)
  • Oberoi Realty
    1,912.00 1,985.00(%)
  • Antelopus Selan
    1,035.95 951.45(%)
  • IFCI
    95.91 46.20(%)
  • Godrej Consumer
    859.50 891.10(%)
  • HDFC Bank
    712.75 1,020.35(%)
  • Kesar India
    1,341.00 1,340.00(%)
  • JSW Holdings
    11,400.05 10,500.05(%)
  • TBO Tek
    1,733.30 1,764.00(%)
  • Milky Mist Dairy
    268.75 255.10(%)
  • Max Healthcare
    985.30 903.50(%)
  • Solar Industries
    21,634.10 20,760.15(%)
  • Piramal Pharma
    216.40 220.40(%)
  • Divi's Lab.
    9,277.55 9,296.00(%)
  • Coal India
    428.40 490.90(%)
  • Ather Energy
    1,630.00 481.25(%)
  • Bajaj Finance
    1,035.05 788.40(%)
  • Reliance Industries
    1,305.05 1,250.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Symbiotec Pharmalab Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 36114.0
  • ISIN : INE899I01028
1,092.80 -5 (-0.45%)
  • As on 03 Sep 2026 (EOD)

  • Today’s Low

    1,085.10

  • Today’s High

    1,161.00

  • Open

    1,110.00

  • Perv Close

    1,097.70

  • 52W Low

    934.20

  • 52W High

    1,180.00

Key Indicators

  • P/E(TTM)

    48.11

  • Mar.Cap (₹Cr.)

    7,021.91

  • Div & Yield %

    0.00

  • Book Value(₹)

    195.23

  • Debt-Equity Ratio

    -0.45

  • AGM Date

    02-Sep-2026

  • EPS

    22.70

  • P/E Ratio

    48.11

Financials Ratios

  • Debt-Equity Ratio

    0.35

  • Mar.Cap (₹Cr.)

    7,021.91

  • RONW (%)

    15.18

  • ROCE (%)

    15.39

Score Board

  • Equity (₹ in Cr.)

    12.85

  • BV (₹)

    195.20

  • Sales( ₹ in Cr.)

    756.68

  • NP (in Cr.)

    145.83

  • NP Var(%)

    64.0

  • Div%

    0.0

  • CPS (₹)

    28.70

  • EPS (₹)

    22.70

  • Traded Value (₹ in Lakhs)

    7,018.05

  • 52 Week High

    1,180.00

  • 52 Week Low

    934.20

  • Price BSE

    1092.0

  • Price NSE

    1,093.00

  • Market Capital( in Cr.)

    7,018.05

  • P/C Ratio

    38.10

  • P/E Ratio

    48.10

  • Price Vs.BV

    22.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 756.68 673.61 563.59 633.85 622.86 531.19
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 756.68 673.61 563.59 633.85 622.86 531.19
Other Income 32.00 19.76 12.37 5.65 9.01 3.17
Stock Adjustments -11.91 -6.33 14.78 1.52 -2.29 56.90
Total Income 776.77 687.04 590.74 641.02 629.58 591.26
EXPENDITURE :            
Raw Materials 288.02 315.25 304.57 359.86 263.81 313.93
Power and Fuel Cost 29.13 31.17 28.75 27.56 24.57 23.21
Employee Cost 119.02 101.60 92.55 81.74 72.77 64.47
Other Manufacturing Expenses 50.54 41.73 33.60 22.05 18.88 17.93
Selling and Administration Expenses 22.41 19.22 20.64 18.42 21.04 26.24
Miscellaneous Expenses 16.63 15.38 82.74 20.44 17.14 22.93
Employee Benefit Expenses 119.02 101.60 92.55 81.74 72.77 64.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 525.75 524.35 562.85 530.06 418.21 468.71
Operating Profit 251.03 162.70 27.89 110.95 211.38 122.56
Interest 16.65 7.54 8.05 3.07 6.52 10.61
Gross Profit 234.38 155.16 19.84 107.88 204.86 111.95
Depreciation 38.36 37.26 27.62 25.11 22.18 21.16
Profit Before Tax 196.02 117.90 -7.78 82.77 182.68 90.79
Current Tax 47.39 28.30 15.16 21.05 46.44 21.55
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.81 0.65 -0.28 0.00 0.67 -3.28
Reported Net Profit 145.83 88.95 -22.66 61.73 135.56 72.52
Extraordinary Items 0.00 0.01 -79.65 0.00 0.01 -0.21
Adjusted Net Profit 145.83 88.94 56.99 61.73 135.55 72.73
Adjustment below Net Profit -0.48 -0.62 0.29 0.10 -0.04 0.09
P & L Balance brought forward 589.07 500.75 523.11 461.29 325.77 253.16
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 734.43 589.07 500.75 523.11 461.29 325.77
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 133.35 81.33 -20.72 56.45 123.96 66.31
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 832.83 695.99 615.23 635.68 579.15 455.22
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    33.28%

  • Public Share Holding

    66.72%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 9,819,885 15.28 9,819,885 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,815,730 10.61 6,815,730 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 4,748,208 7.39 4,748,208 3
Others 0 0.00 0 0
Sub Total 21,383,823 33.28 21,383,823 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 11,825,492 18.40 11,825,492 3
Financial Institutions / Banks 1,730,057 2.69 1,730,057 37
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,718,925 2.68 1,718,925 48
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 687,156 1.07 687,156 18
Mutual Funds / UTI 3,558,887 5.54 3,558,887 16
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,706,127 18.22 11,706,127 91
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 31,226,644 48.60 31,226,644 213
2] Non Institution
Bodies Corporate 65,517 0.10 65,517 72
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 586,927 0.91 586,927 357
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 610,198 0.95 610,198 3
Individuals holding nominal share capital up to Rs. 1 lakh 10,056,648 15.65 10,056,648 427,052
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 82,695 0.13 82,695 2
Sub Total 11,645,645 18.12 11,645,645 427,508
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 64,256,112 100.00 64,256,112 427,730

Company Background

Symbiotec Pharmalab LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Symbiotec Pharmalab Ltd
  • BSE Code : 36114.0
  • ISIN : INE899I01028

  • Incorporation Year

    2002

  • Registered Office

    385/2 Pigdamber Near
    Mashal Hotel Rau, Indore,
    Madhya Pradesh-453331

  • Telephone

    +91-731-6676405

  • FAX

  • Chairman

  • Managing Director

    ANIL KUMAR SATWANI

  • Company Secretary

    Salil Jain

  • Auditor

    SRBC & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Symbiotec Pharmalab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Symbiotec Pharma 1,092.20 788.69 756.68 48.11 20.81
Abbott India 26,025.15 7,217.19 6,929.05 34.25 43.78
Astrazeneca Phar 6,870.25 2,304.07 2,275.58 101.26 27.86
Glaxosmi. Pharma 2,946.60 3,932.76 3,790.20 47.07 58.17
Novartis India 1,602.15 398.23 356.27 40.46 16.64
Cipla 1,413.15 20,102.60 18,979.95 37.14 13.88
Bliss GVS Pharma 649.00 773.53 729.81 60.26 12.51
Fermenta Biotec. 522.75 474.15 450.25 24.40 18.77
Amrutanjan Healt 501.90 520.13 502.55 26.88 24.16
Guj. Themis Bio. 412.60 152.47 150.80 110.32 27.21
Ambalal Sarabhai 44.79 19.52 3.94 82.94 6.77